von Rosenvinge EC

No ORCID on file · 1 paper in corpus

2025

Is the current regulatory framework for direct-to-consumer microbiome-based tests sufficient to protect consumers from medical, economic, and dignitary harms?

Journal of law and the biosciences ·doi:10.1093/jlb/lsaf024

This article offers a thorough analysis of an important public health issue-the lack of regulation of companies selling direct-to-consumer (DTC) microbiome-based tests. These companies invite curious consumers and desperate patients to subm…